Concentrix (NASDAQ:CNXC) Issues FY 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 10.830-11.180 for the period, compared to the consensus earnings per share estimate of 11.450. The company issued revenue guidance of $9.9 billion-$10.0 billion, compared to the consensus revenue estimate of $10.1 billion. Concentrix also updated its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Price Performance

NASDAQ CNXC traded up $0.23 during trading on Monday, hitting $25.23. 3,077,140 shares of the company’s stock were exchanged, compared to its average volume of 1,607,306. The company has a market cap of $1.54 billion, a PE ratio of -1.17, a P/E/G ratio of 0.31 and a beta of 0.43. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.43. Concentrix has a fifty-two week low of $22.05 and a fifty-two week high of $62.14. The stock’s 50 day moving average price is $25.93 and its two-hundred day moving average price is $32.17.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Concentrix in a report on Monday, June 22nd. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Wall Street Zen downgraded shares of Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Canaccord Genuity Group cut their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, March 25th. Finally, Robert W. Baird reduced their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $44.33.

Insider Buying and Selling

In related news, CFO Andre S. Valentine bought 2,500 shares of Concentrix stock in a transaction that occurred on Thursday, April 9th. The shares were acquired at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the acquisition, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at approximately $2,489,394.70. The trade was a 2.89% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider directly owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The SEC filing for this sale provides additional information. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Concentrix

Hedge funds and other institutional investors have recently bought and sold shares of the company. AQR Capital Management LLC boosted its position in Concentrix by 25.5% during the second quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock valued at $226,252,000 after acquiring an additional 875,556 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Concentrix by 28.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after acquiring an additional 551,778 shares in the last quarter. Alyeska Investment Group L.P. acquired a new position in shares of Concentrix in the 4th quarter valued at about $22,913,000. Bank of New York Mellon Corp lifted its stake in shares of Concentrix by 157.1% in the 4th quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after purchasing an additional 433,731 shares during the period. Finally, Marshall Wace LLP lifted its stake in shares of Concentrix by 1,062.2% in the 4th quarter. Marshall Wace LLP now owns 394,686 shares of the company’s stock valued at $16,411,000 after purchasing an additional 360,725 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.